Hypodermoclysis as an Alternative to Pediatric Rehydration

Main Article Content

Mónica D’Amato G.
Alejandra Escobar V.
Mauricio Fernández L.
Jose E. Irazuzta

Abstract

Dehydration is one of the main causes of mortality in pediatric population in developing countries. Thus, we have studied alternative measures that are low-cost and easy to administer for oral, intravenous, and intraosseuos rehydration. Hypodermoclysis is the technique for subcutaneous administration of liquids in order to prevent or treat mild or moderate dehydration. This method has been forgotten for many years due to the lack of experience and well-structured protocols. Recently, there has been increasing interest in researching and implementing this technique due to the benefits and lower risks compared to other options, including easy administration, pathway maintenance, patient comfort, and reduced complications due to endothelial damage, demonstrated in different studies, such as INFUSE-Peds I and II. Human recombinant hyaluronidase can be implemented in order to favor subcutaneous absorption; this enzyme is in charge of dissolving hyaluronic acid to temporarily alter the permeability of the tissue, which is the object of analysis of these studies. This technique has not been completely disseminated in Colombia to administer in pediatric population. It is imperative to divulge treatment options that are effective and low-cost to treat the most prevalent diseases. Hypodermoclysis meets these objectives and also has benefits such as parent satisfaction and improves indexes of infant morbidity and mortality.

Keywords:
hypodermoclysis, dehydration, rehydration solutions

Article Details

Author Biographies

Mónica D’Amato G., Pontifical Bolivarian University

Pediatric Resident first year. Pontifical Bolivarian University. Medellin Colombia.

Alejandra Escobar V., Universidad CES

Second year Pediatric Resident. CES University. Medellin Colombia.

Mauricio Fernández L., Universidad CES

Intensivist Pediatrician. Pediatrics Program Coordinator. School of Medicine. CES University. Medellin Colombia.

Jose E. Irazuzta, Florida University

Intensivist Pediatrician. University of Florida. Florida, United States.Pediatra Intensivista. University of Florida. Flórida, Estados Unidos.

References

Humphrey P. Hypodermoclysis: An alternative to I.V. infusion therapy. Nursing. 2011; 41:16-17.

Barua P, Bhowmick BK. Hypodermoclysis: A victim of historical prejudice. Age and Ageing. 2005; 34:215–217.

Spandorfer PR. Subcutaneous rehydration. Updating a traditional technique. Pediatr Emerg Care. 2011; 27:230-236.

Jain S, Mansfield B, Wilcox MH. Subcutaneous fluid administration, better than the intravenous approach? J Hosp Infect. 1999; 41:269-272.

Enciso LF, Pareja DM. Hipodermoclisis: un tratamiento seguro, eficaz y de bajo costo para el manejo de pacientes [monografía]. Bogotá. Universidad Nacional de Colombia; 2009.

Camacho MI, Acevedo A, Santacruz JG. Uso del catéter subcutáneo (CS) en el programa de cuidado paliativo domiciliario de la Fundación Santa Fe de Bogotá. Rev Colombiana de Hematología y Oncología. 2012; 1:33.

Slesak G, Schnürle JW, Kinzel E, Jakob J, Dietz PK. Comparirson of subcutaneous and intravenous rehydration in geriatric patients: A randomized trial. J Am Geriatr Soc. 2003; 51: 155-160.

Arinzon Z, Feldman J, Fidelman Z, Gepstein R, Berner YN. Hypodermoclysis (subcutaneous infusion) effective mode of treatment of dehydration in long-term care patients. Arch Gerontol Geriatr. 2004; 38:167-173.

Lybarger EH. Hypodermoclysis in the home and long-term care settings. J Infus Nurs. 2009; 32:40-44.

Brugnolli A, Bevilacqua A, Clodig M. Hypodermoclysis hydration in the elderly. Assist Inferm Ric. 2012; 31:145-150.

Niescierenko M, Bachur R. Advances in pediatric dehydration therapy. Curr Opin Pediatr. 2013; 25:304–309.

Jiménez S, Rodríguez J. Deshidratación aguda. Rehidratación Bol Pediatr. 2006; 46:84-90.

Centro Nacional de Investigación y Tecnologías en Salud (Cinets). Guía de práctica clínica para prevención, diagnóstico y tratamiento de la enfermedad diarreica aguda en niños menores de 5 años. Bogotá. Ministerio de Salud y Protección Social Colciencias; 2013.

WHO. The treatment of diarrhea. A manual for physicians and other senior health workers. Department of Child and Adolescent Health and Development. Geneva: WHO; 2005. Disponible en: http://whqlibdoc.who.int/publications/2005/9241593180.pdf?ua=1.

Botas I, Ferreiro A, Soria B. Deshidratación en niños. An Med (Méx.) 2011; 56:146-155.

Canavan A, Arant B. Diagnosis and management of dehydration in children. Am Fam Physician. 2009; 80:692-696.

Jablonski S. Oral rehydration of the pediatric patient with mild to moderate dehydration. J Emerg Nurs. 2012; 38:185-187.

Kuensting L. Comparing subcutaneous fluid infusion with intravenous fluid infusion in children. J Emerg Nurs. 2013; 39:86-91.

Rouhani S, Meloney L, Ahn R, Nelson BD, Burke TF. Alternative rehydration methods: A systematic review and lessons for resource-limited care. Pediatrics. 2011; 127:e748-757.

Lopez JH, Reyes-Ortiz CA. Subcutaneous hydration by hypodermoclysis. Reviews in Clinical Gerontology. 2010; 1:9.

Turner T, Cassano AM. Subcutaneous dextrose for rehydration of elderly patients- an evidencebased review. BMC Geriatr. 2004; 15;4:2.

Huffman G.B. Hypodermoclysis: A cure for moderate dehydration. Am Fam Physician. 1999; 59:2617-2620.

Yap LK, Tan SH, Koo WH. Hypodermoclysis or subcutaneous infusion revisited. Singapore Med J. 2001; 42:526-529.

Gaisford W, Evans DG. Hyaluronidase in paediatric therapy. Lancet. 1949; 2:505-507.

Cubero MI, Machado IS, Fernández ME. Deshidratación aguda en pediatría. Actualización del protocolo de rehidratación en el SUE. Bol SPAO. 2013; 7:148-153.

Challiner YC, Jarrett D, Hayward MJ, al-Jubouri MA, Julious SA. A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients. Postgrad Med J. 1994; 70:195-197.

Lininger RA. Pediatric peripheral I.V. insertion success rates. Pediatr Nurs. 2003; 29:351-354.

King CK, Glass R, Bresee JS, Duggan C, Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: Oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003; 52:1-16.

Spandorfer PR, Alessandrini EA, Joffe MD. Oral versus intravenous rehydration of moderately dehydrated children: A randomized, controlled trial. Pediatrics. 2005; 115:295-301.

Thomas JR, Yocum RC, Haller MF. Assessing the role of human recombinant hyaluronidase in gravity-driven subcutaneous hydration: The INFUSE-LR study. J Palliat Med. 2007; 10:1312-1320.

Schen RJ, Singer-Edelstein M. Subcutaneus infusions in the elderly. J Am Geriatr Soc. 1981; 29:583-585.

Cook LS. Infusion-related air embolism. J Infus Nurs. 2013; 36:26-36.

Bautista-Eugenio V, Salinas-Cruz J. La vía subcutánea opción para el paciente terminal cuando se pierde la vía oral. Rev Enferm Inst Mex Seguro Soc. 2009; 17:149-152.

Sasson M, Shvartzman P. Hypodermoclysis: An alternative infusion technique. Am Fam Physician. 2001; 64:1575–1578.

Hays H. Hypodermoclysis for symptom control in terminal care. Can Family Physician. 1985; 31:1253–1256.

Fallabela R, Escobar CE, Barona MI. Estructura y funciones de la piel. En Falabella R, Chaparro JV, Barona MI, Domínguez L. Dermatología. 6. ed. Medellín: CIB; 2002. p.2-15.

Pirrello RD, Ting Chen C, Thomas SH. Initial experiences with subcutaneous recombinant human hyaluronidase. J Palliat Med. 2007; 10:861-864.

Meyer K. The biological significance of hyaluronic acid and hyaluronidase. Physiol Rev. 1947; 27:335-359.

Chain E, Duthie E. Identity of hyaluronidase as spreading factor. Br J Exp Pathol. 1940; 21:324- 338.

Dolamore M. The use of hypodermoclysis without hyaluronidase. J Am Med Dir Assoc. 2009. 1:75.

Yocum RC, Kennard D, Heiner LS. Assessment and implication of the allergic sensitivity to a single dose of recombinant human hyaluronidase injection: A double-blind, placebocontrolled clinical trial. J Infus Nurs. 2007; 30:293–299.

Dychter SS, Ebel D, Mead TR, Yocum RC. Comparison of the tolerability of recombinant human hyaluronidase normal saline and recombinant human hyaluronidase lactated ringer’s solution administered subcutaneously: A phase IV, double-blind, randomized pilot study in healthy volunteers. Curr Ther Res Clin Exp. 2009; 70:421–438.

Wasserman RL. Overview of recombinant human hyaluronidase-facilitated subcutaneus infusión of IgG in primary immunodeficiencies. Immunotherapy. 2014; 6:553-567.

Slesak G, Schnürle JW, Kinzel E, Jakob J, Dietz PK. Subcutaneous and intravenous infusions were similarly well accepted, safe, and feasible in older patients with Dehydration. J Am Geriatr Soc. 2003; 51:155–160.

Gallardo R, Gamboa F. Uso de la vía subcutánea en cuidados paliativos. Monografías Secpal. 2013; (4): 48-56.

Eldridge DL. Alternatives to intravenous rehydration in dehydrated pediatric patients with difficult venous access. Pediatr Emerg Care. 2010; 26:529-535.

Gluck SM. Hypodermoclysis revisited. JAMA. 1982; 248:1310-1311.

Allen CH, Etzwiler LS, Miller MK, Maher G, Mace S, Hostetler MA, et al. Recombinant human hyaluronidase-enabled subcutaneous pediatric rehydration. Pediatrics. 2009; 124:e858–867.

Spandorfer PR, Mace SE, Okada PJ, Simon HK, Allen CH, Spiro DM, et al. A randomized clinical trial of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in mild to moderately dehydrated children in the emergency department. Clinical Therapeutics. 2012; 34: 2232-2245.

Cáceres DC, Estrada E, De Antonio R, Peláez D. La enfermedad diarreica aguda: un reto para la salud pública en Colombia. Rev Panam Salud Pública. 2005; 17:6-14.

Most read articles by the same author(s)